Autophagy—the cell's self-cleaning system—has long been linked to aging and lifespan extension across species. However, this study reveals that one key autophagy protein, ATG-18, works through an unexpected pathway in C. elegans worms. The researchers used a well-established longevity model: removing or disabling the germline (reproductive tissue) naturally extends worm lifespan, and they wanted to understand which genes drive this effect.
The team systematically knocked down autophagy genes in specific tissues (neurons and intestine) to test their necessity for germline-mediated longevity. Surprisingly, only ATG-18 knockdown abolished the lifespan extension, even though all tested autophagy genes successfully reduced autophagy activity. This disconnect was key: the protein's longevity function appears independent of autophagy itself. Through proteomics screening, they identified that ATG-18 physically interacts with PCK-2, an enzyme involved in glucose metabolism, and that this interaction is critical for lifespan extension.
Further experiments strengthened the case: PCK-2 levels rise in the intestine when the germline is absent, and this upregulation requires ATG-18's non-autophagic function. When researchers overexpressed PCK-2 to trigger longevity, it still depended on ATG-18 but not on ATG-2 (a protein that partners with ATG-18 in classical autophagy), confirming the autophagy-independent mechanism.
A major limitation is that all findings come from C. elegans, a small roundworm with ~300 neurons and vastly simpler physiology than humans. While C. elegans is a gold-standard aging model and ATG-18's human ortholog (WIPI2) exists, we cannot assume this mechanism translates to people. The study is also newly published with zero citations, so independent replication is pending. Additionally, the mechanistic chain (how ATG-18-PCK-2 signaling extends lifespan at the cellular level) remains incomplete—the authors identified the key players but not the full downstream pathway.
This work matters because it expands our understanding of autophagy proteins beyond their textbook role. Many drugs and interventions target autophagy broadly; if ATG-18's longevity benefit is non-autophagic, standard autophagy-boosting approaches might miss critical functions. The finding also highlights that cellular signals from the reproductive system (a known longevity brake) may operate through metabolic reprogramming in the intestine and nervous system, pointing toward tissue-specific interventions. For longevity research, this is methodologically rigorous but preliminary—a foundation for follow-up studies in mammals.
0 Comments
Log in to join the discussion.